Pharmacology of Uterine Relaxants (Tocolytics)
1. Introduction/Overview Uterine relaxants, commonly termed tocolytics, constitute a pharmacotherapeutic class of agents designed to inhibit uterine contractions. The primary clinical objective of tocolytic therapy is the prevention or delay of preterm birth, a leading global cause of neonatal morbidity and mortality. Preterm birth, defined as delivery occurring before 37 completed weeks of gestation, presents … Read more